Serum uric acid levels and incidence of impaired fasting glucose and type 2 diabetes mellitus: A meta-analysis of cohort studies

Diabetes Research and Clinical Practice

Volumn 101, Issue 1, 2013, Pages 88-96

  Jia, Zhaotong ^a   Zhang, Xiaoqian ^a   Kang, Shan ^b   Wu, Yili ^b  

^a QINGDAO UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Dose response analysis; Meta analysis; Serum uric acid; Type 2 diabetes mellitus

Indexed keywords

URIC ACID; BIOLOGICAL MARKER;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; FAMILY HISTORY; FEMALE; HUMAN; HYPERURICEMIA; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; URIC ACID BLOOD LEVEL; BLOOD; CHINA; DIABETES MELLITUS, TYPE 2; DIET RESTRICTION; PREDIABETIC STATE; PROGNOSIS;

BIOLOGICAL MARKERS; CHINA; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FASTING; HUMANS; INCIDENCE; PREDIABETIC STATE; PROGNOSIS; RISK FACTORS; URIC ACID;

EID: 84879606676     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.03.026     Document Type: Article

References (42)

1. Whiting D.R., Guariguata L., Weil C., Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diab Res Clin Pract 2011, 94:311-321.
2. Yach D., Stuckler D., Brownell K.D. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 2006, 12:62-66.
3. Corry D.B., Eslami P., Yamamoto K., Nyby M.D., Makino H., Tuck M.L. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 2008, 26:269-275.
4. Sautin Y.Y., Nakagawa T., Zharikov S., Johnson R.J. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007, 293:C584-C596.
5. Lazzeri C., Valente S., Chiostri M., Sori A., Bernardo P., Gensini G.F. Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. Int J Cardiol 2010, 138:206-209.
6. Johnson R.J., Perez-Pozo S.E., Sautin Y.Y., Manitius J., Sanchez-Lozada L.G., Feig D.I., et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?. Endocr Rev 2009, 30:96-116.
7. Krishnan E., Pandya B.J., Chung L., Hariri A., Dabbous O. Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol 2012, 176:108-116.
8. Grundy S.M. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007, 92:399-404.
9. Desquilbet L., Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 2010, 29:1037-1057.
10. Larsson S.C., Orsini N. Coffee consumption and risk of stroke: a dose-response meta-analysis of prospective studies. Am J Epidemiol 2011, 174:993-1001.
11. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
12. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
13. Stephen S. Meta-analysis regression. Stata Tech Bull 1998, 42:16-22.
14. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 1999, 47:15-17.
15. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
16. Patsopoulos N.A., Evangelou E., Ioannidis J.P. Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol 2008, 37:1148-1157.
17. Orsini N., Li R., Wolk A., Khudyakov P., Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012, 175:66-73.
18. Durrleman S., Simon R. Flexible regression models with cubic splines. Stat Med 1989, 8:551-561.
19. Orsini N., Bellocco R.S.G. Generalized least squares for trend estimation of summarized dose-response data. Stata J 2006, 6:40-57.
20. Jackson D., White I.R., Thompson S.G. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Stat Med 2010, 29:1282-1297.
21. Greenland S., Longnecker M.P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992, 135:1301-1309.
22. Perry I.J., Wannamethee S.G., Walker M.K., Thomson A.G., Whincup P.H., Shaper A.G. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ 1995, 310:560-564.
23. Chou P., Li C.L., Wu G.S., Tsai S.T. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes. Diab Care 1998, 21:1183-1187.
24. Taniguchi Y., Hayashi T., Tsumura K., Endo G., Fujii S., Okada K. Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka health survey. J Hypertens 2001, 19:1209-1215.
25. Nakanishi N., Okamoto M., Yoshida H., Matsuo Y., Suzuki K., Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur J Epidemiol 2003, 18:523-530.
26. Chien K.L., Chen M.F., Hsu H.C., Chang W.T., Su T.C., Lee Y.T., et al. Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem 2008, 54:310-316.
27. Choi H.K., De Vera M.A., Krishnan E. Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology (Oxford) 2008, 47:1567-1570.
28. Dehghan A., van Hoek M., Sijbrands E.J., Hofman A., Witteman J.C. High serum uric acid as a novel risk factor for type 2 diabetes. Diab Care 2008, 31:361-362.
29. Bhole V., Choi J.W., Kim S.W., de Vera M., Choi H. Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med 2010, 123:957-961.
30. Viazzi F., Leoncini G., Vercelli M., Deferrari G., Pontremoli R. Serum uric acid levels predict new-onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study. Diab Care 2011, 34:126-128.
31. Wang T., Bi Y., Xu M., Huang Y., Xu Y., Li X., et al. Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine 2011, 40:109-116.
32. Yamada T., Fukatsu M., Suzuki S., Wada T., Joh T. Elevated serum uric acid predicts impaired fasting glucose and type 2 diabetes only among Japanese women undergoing health checkups. Diab Metab 2011, 37:252-258.
33. Wiik B.P., Larstorp A.C., Hoieggen A., Kjeldsen S.E., Olsen M.H., Ibsen H., et al. Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: the LIFE study. Am J Hypertens 2010, 23:845-851.
34. Ohlson L.O., Larsson B., Bjorntorp P., Eriksson H., Svardsudd K., Welin L., et al. Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia 1988, 31:798-805.
35. Lin K.C., Tsai S.T., Lin H.Y., Chou P. Different progressions of hyperglycemia and diabetes among hyperuricemic men and women in the kinmen study. J Rheumatol 2004, 31:1159-1165.
36. Rathmann W., Strassburger K., Heier M., Holle R., Thorand B., Giani G., et al. Incidence of type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. Diab Med 2009, 26:1212-1219.
37. Kramer C.K., von Muhlen D., Jassal S.K., Barrett-Connor E. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo study. Diab Care 2009, 32:1272-1273.
38. Kodama S., Saito K., Yachi Y., Asumi M., Sugawara A., Totsuka K., et al. Association between serum uric acid and development of type 2 diabetes. Diab Care 2009, 32:1737-1742.
39. Kahn B.B., Flier J.S. Obesity and insulin resistance. J Clin Invest 2000, 106:473-481.
40. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 114:1752-1761.
41. Roy D., Perreault M., Marette A. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. Am J Physiol 1998, 274:E692-E699.
42. So A., Thorens B. Uric acid transport and disease. J Clin Invest 2010, 120:1791-1799.